Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
George Kassimis, Giovanni Luigi De Maria, Niket Patel & Adrian P Banning. (2014) Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?. Expert Review of Cardiovascular Therapy 12:8, pages 997-1003.
Read now
Read now
Articles from other publishers (7)
Anne M. Kerola, Anne Grete Semb, Markus Juonala, Antti Palomäki, Päivi Rautava & Ville Kytö. (2022) Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction. Cardiovascular Diabetology 21:1.
Crossref
Crossref
Francesca Razzi, Matija Lovrak, Dovile Gruzdyte, Yvette Den Hartog, Dirk J. Duncker, Jan H. van Esch, Volkert van Steijn & Heleen M. M. van Beusekom. (2021) An Implantable Artificial Atherosclerotic Plaque as a Novel Approach for Drug Transport Studies on Drug‐Eluting Stents. Advanced Healthcare Materials 11:6, pages 2101570.
Crossref
Crossref
Juan F. Iglesias, Dik Heg, Marco Roffi, David Tüller, Jonas Lanz, Fabio Rigamonti, Olivier Muller, Igal Moarof, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Florim Cuculi, Marco Valgimigli, Peter Jüni, Stephan Windecker & Thomas Pilgrim. (2019) Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents. Journal of the American Heart Association 8:22.
Crossref
Crossref
Zhengbin Zhu, Yongjian Wu, Zhujun Shen, Yawei Xu, Yigang Li, Yan Wang, Xi Su, Bao Li, Tiemin Jiang, Jinfa Jiang, Lefeng Wang, Shenghu He, Xueqi Li, Hongwei Li, Yin Liu, Yujie Zhou, Qiang Tang, Yundai Chen, Weiyi Fang, Li Jiang, Chengzhi Lu, Jincheng Guo, Jianjun Zhang, Shaoliang Chen, Yong Xia, Hongchao Zheng, Bin Wang, Daifu Zhang, Liuliu Feng, Lijiang Tang, Peng Xu, Xuebo Liu & Ruiyan Zhang. (2019) Safety and efficacy of zotarolimus-eluting stents in the treatment of diabetic coronary lesions in Chinese patients: The RESOLUTE-DIABETES CHINA Study. Journal of Diabetes 11:3, pages 204-213.
Crossref
Crossref
Maayan Konigstein, Ori Ben-Yehuda, Pieter C. Smits, Michael P. Love, Shmuel Banai, Gidon Y. Perlman, Mordechai Golomb, Melek Ozgu Ozan, Mengdan Liu, Martin B. Leon, Gregg W. Stone & David E. Kandzari. (2018) Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents. JACC: Cardiovascular Interventions 11:24, pages 2467-2476.
Crossref
Crossref
Carlos M. Campos, Adriano Caixeta, Marcelo Franken, Antonio L. Bartorelli, Robert J. Whitbourn, Chiung-Jen Wu, Hsien Li Paul Kao, Mohd Ali Rosli, Didier Carrie, Bernard De Bruyne, Gregg W. Stone, Patrick W. Serruys & Alexandre Abizaid. (2018) Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SP. Catheterization and Cardiovascular Interventions 91:3, pages 387-395.
Crossref
Crossref
C. M. McKittrick, S. Kennedy, K. G. Oldroyd, S. McGinty & C. McCormick. (2015) Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents. Annals of Biomedical Engineering 44:2, pages 477-487.
Crossref
Crossref